Analyst coverage – Oasmia

Thomas Nilsson

Thomas Nilsson

Read more

Dr Joseph Hedden

Oasmia Pharmaceutical AB – In-licenses clinical-stage ovarian cancer drug

Oasmia Pharmaceutical AB – Phase Ib of docetaxel micellar in prostate cancer authorised

Klas Palin

Read more

Dr Susie Jana & Dr John Priestner

Read more